Neuropsychiatry of complex visual hallucinations

Australian and New Zealand Journal of Psychiatry

Volumn 40, Issue 9, 2006, Pages 742-751

  Mocellin, Ramon ^b   Walterfang, Mark ^a   Velakoulis, Dennis ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Charles Bonnet; Hallucinosis; Peduncular; Vascular; Visual hallucination

Indexed keywords

4 AMINOBUTYRIC ACID; AMLODIPINE; ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLIPIZIDE; IRBESARTAN; METFORMIN; N METHYL DEXTRO ASPARTIC ACID; OLANZAPINE; PHENYTOIN; RISPERIDONE; SIMVASTATIN; TIMOLOL;

AIDS RELATED COMPLEX; ARTIFICIAL EMBOLISM; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN REGION; BRAIN STEM INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATARACT EXTRACTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHARLES BONNET SYNDROME; CLINICAL FEATURE; COMPLEX VISUAL HALLUCINATION; DEMENTIA; DIABETES CONTROL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; ENCEPHALOMYELITIS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HALLUCINOSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LASER COAGULATION; MIGRAINE; MINI MENTAL STATE EXAMINATION; MULTIPLE SCLEROSIS; NEUROPSYCHIATRY; OLFACTORY BULB; OPHTHALMOSCOPY; OPTICAL INSTRUMENTATION; PATHOPHYSIOLOGY; PEDUNCULAR HALLUCINOSIS; PERCEPTION DISORDER; PHENOMENOLOGY; PONS ANGLE; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCHIZOPHRENIA; SLEEP; SUBSTANCE ABUSE; SURGICAL TECHNIQUE; SYMPTOM; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; VISUAL FIELD DEFECT; VISUAL HALLUCINATION; VISUAL IMPAIRMENT; VISUAL MEMORY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN INFARCTION; FEMALE; HALLUCINATIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MESENCEPHALON; VISUAL PATHWAYS;

EID: 33746637259     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1111/j.1440-1614.2006.01878.x     Document Type: Review

References (71)

1. Folstein M, Folstein S, McHugh P. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975; 12:189-198.
2. Esquirol E. Des maladies mentales considerees sous les rapports medicaux, hygieniques et medico-legaux. Paris: Bailliere, 1838.
3. Slade P. Hallucinations. Psychological Medicine 1976; 6:7-13.
4. Slade P, Bentall R. Sensory deception: A scientific analysis of hallucinations. Baltimore, MD: Johns Hopkins University Press, 1988.
5. Association AP. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
6. Bentall R. The illusion of reality: A review and integration of psychological research on hallucinations. Psychological Bulletin 1990; 107:82-95.
7. Kandinsky V. O psevdohallucinatsiakh. Kritiko-klinicheskii etud. St Petersburg: Isdanie EK Kandinskoi, 1890.
8. Sims A. Symptoms in the mind: An introduction to descriptive psychopathology, 2nd edn. London: W.B. Saunders, 1995.
9. Johns L. Hallucinations in the general population. Current Psychiatry Reports 2005; 7:162-167.
10. Johns L, van Os J. The continuity of psychotic experiences in the general population. Clinical Psychology Review 2001; 21:1125-1141.
11. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. II: Disordes of perception. British Journal of Psychiatry 1990; 157:76-81.
12. Teunisse R, Cruysberg J, Hoefnagels W et al. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996; 347:794-797.
13. Vaphiades M, Celesia G, Brigell M. Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways. Neurology 1996; 47:408-417.
14. World Health Organisation. The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: WHO, 1992.
15. Sachdev P. A critique of 'organic' and its proposed alternatives. Australian and New Zealand Journal of Psychiatry 1996; 30:165-170.
16. Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998; 121 (Pt 10):1819-1840.
17. Grieve K, Acuna C, Cudeiro J. The primate pulvinar nuclei: Vision and action. Trends in Neurosciences 2000; 23:35-39.
18. Burke W. The neural basis of Charles Bonnet hallucinations: A hypothesis. [Comment]. Journal of Neurology, Neurosurgery and Psychiatry 2002; 73:535-541.
19. Abrams J, Johnson P, Hollis J et al. Anatomic and functional topography of the dorsal raphe nucleus. Annals of the New York Academy of Sciences 2004; 1018:46-57.
20. Wu M, John J, Boehmer L et al. Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs. Journal of Physiology 2004; 554 (Pt 1):202-215.
21. Pollen D. On the neural correlates of visual perception. Cerebral Cortex 1999; 9:4-19.
22. Kolmel H. Complex visual hallucinations in the hemianopic field. Journal of Neurology, Neurosurgery and Psychiatry 1985; 48:29-38.
23. Waragai M, Takaya Y, Hayashi M. Complex visual hallucinations in the hemianopic field following an ischemic lesion of the occipitotemporal base - confirmation of the lesion by MRI and speculations on the pathophysiology. No to Shinkei - Brain and Nerve 1996; 48:371-376.
24. Rushmore R, Payne B, Lomber S. Functional impact of primary visual cortex deactivation on subcortical target structures in the thalamus and midbrain. Journal of Comparative Neurology 2005; 488:414-426.
25. Diederich N, Goetz C, Stebbins G. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model. Movement Disorders 2005; 20:130-140.
26. Santhouse A, Howard R, Ffytche D. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain 2000; 123 (Pt 10):2055-2064.
27. Merabet L, Maguire D, Warde A et al. Visual hallucinations during prolonged blindfolding in sighted subjects. Journal of Neuro-Opthalmology 2004; 24:109-113.
28. Kolmel H. Peduncular hallucinations. Journal of Neurology 1991; 238:547-549.
29. Lhermitte M. Syndrome de la calotte due penduncule cerebral. Les troubels psycho-sensoriels dans les lesions du mesocephale. Revue de Neurologique (Paris) 1922; 38:1359-1365.
30. van Bogert L. La hallucinose pedunculaire. Revue de Neurologique (Paris) 1927; 43:608-617.
31. de Morsier G. Pathogénie de l'hallucinose pédonculaire, A propos d'un nouveau cas. Schweizerische Medizinische Wochenschrift 1936; 27:645-646.
32. Caplan L. Top of the basilar syndrome. Neurology 1980; 30:72-79.
33. Danziger N, Meary E, Mercier B et al. Visual hallucinosis and hyperhedonism in pontine and thalamic infarction. Revue de Neurologique (Paris) 1997; 153:679-683.
34. Feinberg W, Rapcsak S. Peduncular hallucinosis' following paramedian thalamic infarction. Neurology 1987; 39:1535-1536.
35. Yana K, Kuroda T, Tanabe Y et al. Delayed cerebral ischaemia manifesting as peduncular hallucinosis after aneurysmal subarachnoid haemorrhage - three case reports. Neurologia Medico-Chirurgica 1994; 34:593-596.
36. Maiuri F, Iaconetta G, Sardo L et al. Peduncular hallucinations associated with large posterior fossa meningiomas. Clinical Neurology and Neurosurgery 2002; 104:41-43.
37. Nadvi S, Ramdial P. Transient peduncular hallucinations secondary to brain stem compression by a cerebellar pilocytic astrocytoma. British Journal of Neurosurgery 1999; 12:579-581.
38. Miyzawa T, Fukui S, Otani N et al. Peduncular hallucinosis due to a pineal meningioma. Journal of Neurosurgery 2001; 95:500-502.
39. Podoll K, Robinson D. Recurrent Lilliputian hallucinations as a visual aura symptom in migraine. Cephalalgia 2001; 21:990-992.
40. Bossi L, Nobili M, Benedetto P. Peduncular hallucinosis in a young woman with vertebrobasilar insufficiency. Archivio per le Scienze Mediche 1980; 137:347-350.
41. Kumar R, Behari S, Wahi J et al. Peduncular hallucinosis: An unusual sequel to surgical intervention in the suprasellar region. British Journal of Neurosurgery 1999; 13:500-503.
42. Rosanzki J. Peduncular hallucinations following vertebral angiography. Neurology 1952; 2:341-349.
43. Dunn D, Weisberg L, Nadell J. Peduncular hallucinations caused by brainstem compression. Neurology 1983; 33:1360-1361.
44. Risser A, Powell F. Lhermitte's Peduncular Hallucinosis. In 45th Meeting of the American Academy of Neurology. New York, 1993.
45. Leroy R. Les hallucinations Lilliputiennes. Annals of Medical Psychology 1909; 67:278-289.
46. Leroy R. The affective states in Lilliputian hallucinations. The Journal of Mental Science 1926; 72:179-186.
47. Hendrickson J. Adityanjee. Lilliputian hallucinations and schizophrenia: case report and review of the literature. Psychopathology 1996; 29: 35-38.
48. Kanazawa A, Hata T. Coexistence of the Ekbom syndrome and Lilliputian hallucinations. Psychopathology 1992; 25:209-211.
49. Estler H, Deckert J, Riedmann G et al. Lilliputian and negative hallucinations in a patient with probable encephalomyelitis disseminata. Psychopathology 1995; 28:65-69.
50. Cohen M, Alfonso C, Haque M. Lilliputian hallucinations and medical illness. General Hospital Psychiatry 1994; 16:141-143.
51. Jacome D. Volitional monocular Lilliputian visual hallucinations and synaesthesia. European Neurology 1999; 41:54-56.
52. Harper R, Knothe B. Coloured Lilliputian hallucinations with amantadine. Medical Journal of Australia 1973; 1:444-445.
53. Takaoka K, Takata T. 'Alice in Wonderland' syndrome and Lilliputian hallucinations in a patient with a substance related disorder. Psychopathology 1999; 32:47-49.
54. Cummings J, Miller B. Visual hallucinations. Clinical occurrence and use in differential diagnosis. Western Medical Journal 1987; 146:46-51.
55. Cambier J, Decroix J, Masson C. Auditory hallucinations in lesions of the brain stem. Revue de Neurologique (Paris) 1987; 143:255-262.
56. Cascino G, Adams R. Brainstem auditory hallucinosis. Neurology 1986; 36:1042-1047.
57. Bonnet C. Essai Analytique Sur les Facultés de L'âme, 2nd edn. Copenhagen: C&A Philibert, 1769.
58. Fernandez A, Lichtshein G, Vieweg W. The Charles Bonnet syndrome: A review. Journal of Nervous and Mental Disease 1997; 185: 195-200.
59. Berrios G, Brook P. The Charles Bonnet syndrome and the problem of visual perceptual disorders in the elderly. Age and Ageing 1982; 11:17-23.
60. Ffytche D, Howard R. The perceptual consequences of visual loss: 'positive' pathologies of vision. Brain 1999; 122:1247-1260.
61. Rosenbaum F, Harati Y, Rolak L et al. Visual hallucinations in sane people: Charles Bonnet syndrome. Journal of the American Geriatrics Society 1987; 35:66-68.
62. Menon G, Rahman I, Menon S et al. Complex visual hallucinations in the visually impaired: The Charles Bonnet syndrome. Survey of Ophthalmology 2003; 48:58-72.
63. Coletti Moja M, Milano E, Gasverde S et al. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurological Sciences 2005; 26:168-170.
64. Howard R, Meehan O, Powell R et al. Successful treatment of Charles Bonnet syndrome type visual hallucinosis with low-dose risperidone. International Journal of Geriatric Psychiatry 1994; 9:677-678.
65. Hori H, Terao T, Shirashi Y et al. Treatment of Charles Bonnet syndrome with valproate. International Clinical Psychopharmacology 2000; 15:117-119.
66. Terao T. Effect of carbamazepine and clonazepam combination on Charles Bonnet syndrome: A case report. Human Psychopharmacology: Clinical and Experimental 1998; 13:451-453.
67. Teuth M, Cheong J, Samander J. The Charles Bonnet syndrome: A type of organic visual hallucinosis. Journal of Geriatric Psychiatry and Neurology 1995; 8:1-3.
68. Pankow L, Pliskin N, Luchins D. An optical intervention for visual hallucinations associated with visual impairment and dementia in elderly patients. Journal of Neuropsychiatry and Clinical Neurosciences 1996; 8:88-92.
69. Bellelli G, Bianchetti A, Trabucchi M. Let's strip the king: Eligibility not safety is the problem of anticoagulation for stroke prevention in elderly patients with atrial fibrillation. Archives of Internal Medicine 2002; 162:1067; author reply 1067.
70. Gaddi A, Cicero A, Nascetti S et al. Cerebrovascular disease in Italy and Europe: It is necessary to prevent a 'pandemia'. Gerontology 2003; 49:69-79.
71. Schneider L, Dagerman K, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association 2005; 294:1934-1943.